NEW YORK (GenomeWeb) – Paradigm Diagnostics said today that it has closed a $15 million Series B fundraising, which has been ongoing since 2017. In conjunction with the closing, the firm has added Mara Aspinall, managing director of BlueStone Venture Partners, to its board of directors.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.